The corporate social responsibility projects implemented by Latvia's pharmaceutical company "Olpha" have gained recognition on the global stage. The company has been nominated for the 11th annual "Global Generics and Biosimilars Awards" in the category of "Corporate Social Responsibility." The winners will be announced on October 9 in Milan, Italy.

The panel of experts highly regarded "Olpha's" social initiatives, including the scholarship program for new chemistry and biology teachers titled "Chemistry Among Us," the provision of welcome packages for newborns in the Olaine region, and other support initiatives aimed at improving the health and well-being of Latvian residents. "Olpha's" support for the people of Ukraine was also significant. Since the beginning of the war, "Olpha" has collaborated with several Ukrainian support organizations, providing both financial aid and necessary items. Additionally, the company's collaborations with universities, green energy projects, and environmental protection activities received recognition.

"As a socially responsible company, 'Olpha' aims to contribute as much as possible to improving people's quality of life. Primarily, we do this by offering our patients the chance to regain or improve their health with 'Olpha' products. However, the company views its role in promoting public well-being more broadly, supporting and implementing socially significant projects that foster a better, happier, and healthier community. We are incredibly proud that our efforts have been acknowledged at such a high international level!" said Juris Bundulis, Chairman of the Board of "Olpha."

Alongside various social projects, the company actively implements environmentally friendly solutions, which have enabled a reduction in carbon emissions by 28.6% over the past five years. "Olpha" has also developed renewable energy sources that help achieve energy efficiency goals. In the fall of 2024, a solar panel park was inaugurated on the company's premises, which will provide up to 40% of the company's annual electricity consumption. Additionally, work is underway to establish a new wastewater treatment system.

In early October, "Olpha" will participate in the global pharmaceutical exhibition "CPHI Milan," taking place from October 8-10 in Milan, Italy. The exhibition aims to bring together pharmaceutical industry professionals, companies, and organizations to foster collaboration, innovation, investment, and development.

Participation in this international exhibition is part of the company's efforts to introduce the "Olpha" brand and its pharmaceutical products to Western Europe, with the goal of becoming one of the top ten European pharmaceutical manufacturers in its therapeutic groups as quickly as possible.